TGen Clinical Research

TGen (Translational Genomics Research Institute) is a non-profit biomedical research institute based in Phoenix, Arizona, and an affiliate of City of Hope. The institute is dedicated to conducting groundbreaking research in translational genomics to develop earlier diagnostics and smarter treatments for cancer, neurological disorders, and infectious diseases. Through its clinical research arm, TGen Clinical Research Services (TCRS), and its for-profit subsidiary TGen Drug Development (TD2), the institute bridges the gap between laboratory discovery and patient care by conducting early-phase clinical trials. TGen is a pioneer in precision medicine, utilizing advanced genomic sequencing and bioinformatics to tailor therapies to individual patients. Its work has led to significant advancements in the treatment of pancreatic cancer and the development of rapid genomic diagnostic tools.